Pythia Labs launches AI antibody platform after generating binders against 15 of 22 therapeutic targets
Pythia Labs launches Pythia-1 after designing antibodies against 15 of 22 targets, including seven GPCRs, but clinical validation lies ahead.
Pharma & Biotech